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Lin28 proteins are emerging as important regulators of microRNAs in endocrine systems. Lin28a regulates
primordial germ cell development and puberty timing in mice, whereas the related protein LIN28B is
associated with age at menarche in genome-wide association studies in humans. Here, we studied
expression of LIN28A and LIN28B in early human gonad development. LIN28A increased in the developing
ovary between 6 and 9 weeks post conception, but not in the developing testis. Immunohistochemistry
demonstrated LIN28A in peripheral germ cells. LIN28B was expressed at lower levels in both tissues and
did not increase with time. As disruption of Lin28a affects germ cell development in mice, LIN28A was
considered a candidate gene for primary ovarian insufﬁciency (POI) in humans. However, no signiﬁcant
changes were found in 50 women studied. These ﬁndings show LIN28A is strongly expressed in germ
cells during early human ovary development, but disruption of LIN28A is not a common cause of POI.
 2012 Elsevier Ireland Ltd.Open access under CC BY license. 1. Introduction is strongly associated with age at menarche and stature in severalLIN28A and LIN28B are highly conserved RNA-binding proteins
that block biogenesis of the microRNA (miRNA), let-7, thereby pro-
moting stem/progenitor cell proliferation and inhibiting differenti-
ation (Viswanathan et al., 2008; Viswanathan and Daley, 2010).
These factors are emerging as important regulators of several
endocrine systems. Lin28a (also known as Lin28) regulates primor-
dial germ cell development in mice. Deletion of this gene results in
a reduced germ cell pool in mouse embryos, whereas overexpres-
sion of Lin28a results in greater germ cell number and larger ﬁrst
litter size (West et al., 2009; Zhu et al., 2010). Alterations in this
gene also affect body size, insulin sensitivity and timing of puberty
(Zhu et al., 2010). The related factor, LIN28B has also been impli-
cated in growth and puberty as polymorphic variability in LIN28Bulating hormone; DAPI, 40 ,6-
-phosphate dehydrogenase;
iRNA, microRNA; PBS, phos-
OI, primary ovarian insufﬁ-
Tris-buffered saline with 1%
f Child Health, 30 Guilford
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hermann).
r CC BY license. independent genome-wide association studies in humans (He
et al., 2009, 2010; Ong et al., 2009; Perry et al., 2009; Sulem
et al., 2009; Widen et al., 2010).
Despite these recent advances, relatively little is known about
the role of the LIN28 family of proteins in the developing human
female reproductive system, or in clinical reproductive disorders.
We hypothesized that LIN28A and LIN28B could have an important
role in human germ cell development and expansion of the germ
cell pool, and that disruption of these genes might lead to germ cell
depletion and primary ovarian insufﬁciency (POI). To address this,
a study was undertaken to investigate expression of LIN28A and
LIN28B in early human ovary development and, based on our ﬁnd-
ings, mutational analysis of LIN28A was undertaken in a cohort of
women with POI.2. Materials and methods
2.1. RNA preparation
Human testes and ovaries (n = 3 each) from Carnegie stage (CS)
18–22 (6–7 weeks post conception, wpc), Fetal stage 1 (F1) (8 wpc)
and F2 (9 wpc) were obtained from the Medical Research Council/
Wellcome Trust funded Human Developmental Biology Resource
Table 1
Primers used for DNA ampliﬁcation and sequencing of the four exons of LIN28A.
Exon Primer
name
Primer sequence (50?30) PCR product
size (bp)
Annealing
temp (C)
1 1F tgggtcattgtcttttagaatttgg 295 55
1R cctaggactcagttccccacctc
2 2F tgtccacttgtggggctgga 400 55
2R cccgatggccctcaattcaac
3 3F cacatttgattcctaccctacagga 388 55
3R gggaccacaggcttcccttt
4 4F cagagcccaggtgtcctcattcg 400 55
4R tgccaactagccccaatgcac
F: Forward primer; R: Reverse primer; bp: base pairs
R. El-Khairi et al. /Molecular and Cellular Endocrinology 351 (2012) 264–268 265(HDBR, www.hdbr.org), with Research Ethics Committee approval
and informed consent. Samples were obtained on ice and pre-
served in RNA later (Ambion, Austin, TX, USA). Fetal heart tissue
(8 wpc) was used as a control. RNA was extracted using the Trizol
method and the concentration and ratio of absorbance at 260–
280 nm (A260/A280 ratio) were measured using a NanoDrop ND-
1000 Spectrophotometer (NanoDrop Technologies, Witec, Littau,
Switzerland). First-strand cDNA was synthesized using the Super-
Script II Reverse Transcriptase (Invitrogen, Paisley, UK) and ran-
dom primers according to the manufacturer’s instructions. The
amount of input RNA in each reaction was calculated to be 200 ng.
2.2. qRT-PCR of LIN28A and LIN28B
Primers and TaqMan probes were obtained for LIN28A and
LIN28B (Applied Biosystems, Warrington, UK). Ampliﬁcation was
performed in a total volume of 20 ll per reaction using TaqMan
Gene Expression Master Mix and a StepOnePlus™ Real-time PCR
System (Applied Biosystems). Thermocycling conditions consisted
of an initial step of 2 min at 50 C, denaturation of 10 min at
95 C, followed by 40 cycles of 95 C for 15 s and 60 C for 1 min.
Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH;
4333764T) was used for normalization and relative quantiﬁcation
of gene expression was performed according to the 2DDCt method
(Livak and Schmittgen, 2001). Data were analyzed with StepOne
software version 2.1 and results expressed as fold change above
control.
2.3. Immunohistochemistry of LIN28A
Ovaries from a CS22 embryo (7 wpc) or testis from a F2 fetus
(9 wpc) were obtained from the Human Developmental Biology
Resource, sunk and positioned in Tissue-Tek O.C.T. (Fisher Scien-
tiﬁc, Loughborough, UK) and frozen on dry ice. Frozen sections
were cut at 12–14 microns thickness, collected on Superfrost slides
(Fisher Scientiﬁc), dried and stored at 20 C. For immunohisto-
chemistry, sections were ﬁxed for three minutes by immersion in
4% paraformaldehyde in phosphate-buffered saline (PBS), rinsed
immediately in Tris-buffered saline with 1% Tween 20 (TBST) or
PBS, and incubated for 1 h in blocking buffer (10% Lamb Serum
or 1% BSA in TBST). Sections were incubated overnight at 4 C using
the following primary antibodies: mouse anti-LIN28A monoclonal
(1:200 dilution) (New England Biolabs, Hitchin, UK; 5930S); rabbit
anti-POU5F1 (OCT4) polyclonal (1:200) (Abcam, Cambridge, UK;
Ab19857). Slides were washed in TBST, before incubation over-
night in 40,6-diamidino-2-phenylindol (DAPI) (10 lg/ml) and the
following secondary antibodies: goat anti-mouse polyclonal, con-
jugated to Alexa555 (1:400) (Invitrogen, A11001); goat anti-rabbit
polyclonal, conjugated to Alexa488 (1:400) (Invitrogen, A21429).
Slides were washed and mounted in Vectashield (Vectorlabs,
Peterborough, UK) then visualized on an inverted Zeiss LSM 710
confocal microscope (Carl Zeiss Ltd., Welwyn Garden City, UK).
Controls were obtained following omission of the primary
antibodies.
2.4. Sequence analysis of LIN28A
After institutional board approval and with consent, direct
sequencing of the entire coding region of LIN28A was undertaken
in a cohort of 50 patients with POI of unknown etiology. POI was
deﬁned as amenorrhea of at least six months duration presenting
before the age of 40 years with a serum follicle-stimulating hor-
mone (FSH) measurement of greater than 20 IU/l on two occasions.
This cohort included 13 patients with POI and primary amenorrhea
and 37 women with POI and secondary amenorrhea (mean age of
onset, 24.7 years). A family history of POI was present in 13 cases.Women with Fragile X premutations were excluded and analysis of
the FSH receptor was negative.
Primers were designed using Primer3 online software (version
0.4.0, http://frodo.wi.mit.edu/primer3/) for the four coding exons
of LIN28A (Ensembl transcript ENST00000326279) (Table 1). PCR
reactions were performed using MegaMix (Microzone Ltd., Hay-
wards Heath, UK) and 0.5 ll of forward and reverse primers (5–
25 lM, Euroﬁns MWG Operon, Germany) in 20 ll reaction volume,
for 35 cycles and with an annealing temperature of 55 C. Ampli-
cons were puriﬁed using Microclean (Microzone Ltd.) and then
subjected to direct sequencing using dye terminator sequencing
kits (BigDye Terminator v1.1, Applied Biosystems, Warrington,
UK) using an automated capillary based sequencer (Applied Bio-
systems). Sequencher version 4.6 (Genecodes Corp., Ann Arbor,
MI) was used to analyze the data.3. Results
3.1. LIN28A expression increases at key stages of early human ovary
development
Analysis of LIN28A and LIN28B in human fetal gonads between 6
and 7 wpc showed signiﬁcantly higher expression of LIN28A in the
developing ovary compared to testis and to control tissue (heart)
(Fig. 1A). A further increase in LIN28A transcript levels was seen
with increasing age in the ovary whereas expression levels in the
testis remained constant (Fig. 1A). Differential expression of LIN28B
was also higher in the gonads compared to control tissue (heart),
but did not show marked differences between the ovary and testis
(Fig. 1B).3.2. Immunohistochemistry of LIN28A
Immunohistochemistry revealed strong expression of LIN28A
together with POU5F1 (OCT4) in a population of germ cells in the
developing human ovary at 7 wpc (Fig. 2A). LIN28A staining was
strongest in a population of germ cells at the peripheral cortical re-
gion of the developing gland (Fig. 2B). Consistent with previous
studies in mice, POU5F1 (OCT4) staining was conﬁned to the nu-
cleus of these cells whereas LIN28A staining was found to localize
predominantly in the cytoplasm (Fig. 2C) (West et al., 2009).
LIN28A staining was also seen in the nucleoli of several cells, and
low levels of LIN28A expression was observed in somatic cells.
No signiﬁcant signal was seen in controls.
Immunohistochemistry of human fetal testis at 9 wpc showed
generalized low level expression of LIN28A with denser signal in
the developing seminiferous cords (Fig. 3A). Stronger expression
of LIN28A was generally not seen in POU5F1 (OCT4) positive cells
(Fig. 3B).
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Fig. 1. Expression of LIN28A and LIN28B in the gonad between 6 and 9 weeks post
conception (wpc). (A) Ovary and testis samples showed higher expression of LIN28A
compared to control tissue (heart; 8wpc). Similar results were seen when other
control samples were studied (data not shown). A progressive increase in LIN28A
expression was detected in the ovary up until 9 wpc. (B) LIN28B expression was
higher in the testis and ovary compared to control, but did not show a marked
increase with ovarian age. Data are shown as fold change above control, with
LIN28A and LIN28B expression levels normalized to GAPDH and relative quantiﬁ-
cation of gene expression performed according to the 2DDCt method. Bars
represent 1SD. Note the different scales in panels A and B.
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We hypothesized that LIN28A could regulate primordial germ
cell formation and expansion of the germ cell pool, and that disrup-
tion of LIN28Amight lead to germ cell depletion and primary ovar-
ian insufﬁciency (POI) in humans. Mutational analysis of the
coding regions of LIN28A was therefore undertaken in a cohort of
50 women with POI of unknown etiology. However, no signiﬁcant
non-synonymous changes in the LIN28A gene were found in this
cohort of women with POI.4. Discussion
Primordial germ cells (PGCs) arise from pluripotent epiblast
cells, and proliferate and migrate into the primitive gonad in all
animal species. In humans, this process is thought to occur at
approximately 4–5 weeks post-conception (wpc). In the ovary,
germ cells (oogonia) undergo mitotic proliferation and a dramatic
expansion in numbers. Many of these cells enter the prophase of
meiosis and, following the S phase and almost the entire G2 phase
(during which crossing-over occurs), demonstrate meiotic arrest at
between 8 and 36 weeks (Baker, 1963; Kerr et al., 2008; Le et al.,
2010; Skrzypczak et al., 1981). As a result of the mitotic prolifera-
tion a total of around 7 million germ cells are estimated to bepresent by 20 wpc. Many of these cells undergo apoptosis so that
around 1 million germ cells are present at the time of birth and
around 400 are ovulated during a woman’s reproductive lifespan
(Broekmans et al., 2009). Germ cell formation and migration is
essential for the development and maintenance of follicles in the
ovary and for the organization and maintenance of ovarian struc-
ture. The establishment of primordial follicles early in ovarian
development and their subsequent development into primary fol-
licles has a direct consequence on the number of available oocytes
throughout the female reproductive years (Edson et al., 2009).
Primary ovarian insufﬁciency (POI) is a heterogeneous condi-
tion which affects approximately 1% of women before the age of
40 years (Nelson, 2009). Although several single gene disorders
associated with POI have been described, the underlying mecha-
nisms responsible are likely to be diverse and in most cases are
currently unknown. Studies from mouse models have shown that
defects in PGC migration or proliferation (e.g. Steel, c-kit, Cxcr4)
can be associated with subsequent ovarian germ cell depletion
and ovarian insufﬁciency in postnatal or adult life (Edson et al.,
2009; Jagarlamudi et al., 2010). Fewer data are available for hu-
mans, although it has been proposed that dysregulation of PGC
development may be a mechanism for POI in some individuals.
In order to identify novel genes involved in POI we looked at the
expression of LIN28A and LIN28B in the early human ovary. Lin28a
and Lin28b selectively inhibit the processing of the let-7 family of
miRNA precursors into mature miRNAs (Viswanathan et al., 2008).
LIN28A is emerging as a pluripotency factor and developmental
regulator that may play an important role in promoting progenitor
cell proliferation and in regulating germ cell differentiation in mice
(Viswanathan and Daley, 2010; West et al., 2009; Zhu et al., 2010).
LIN28A is also emerging as an important factor in oncogenesis and
a marker of germ cell tumors in humans (Gillis et al., 2011; Viswa-
nathan et al., 2009; West et al., 2009). Overexpression of LIN28A in
these cells may suppress let-7 processing, resulting in uncontrolled
cell proliferation in the absence of controlled differentiation.
Our expression data show that LIN28A rather than LIN28B pre-
dominates during early human germ cell development. A progres-
sive increase in LIN28A expression was measured by qRT-PCR in
the developing ovary between 6 and 9 wpc. This ﬁnding may rep-
resent an increase in the LIN28A-positive population of germ cells
during this critical early stage of development compared to the tes-
tis or control tissue. Furthermore, immunohistochemistry at 7 wpc
revealed strong expression of LIN28A in a population of peripheral
germ cells in the developing human ovary. These cells co-ex-
pressed nuclear POU5F1 (OCT4) (21) and represent a pool of devel-
oping germ cells. Weaker expression of LIN28A was seen in the
testis, consistent with qRT-PCR ﬁndings. No strong co-localization
with POU5F1 (OCT4) was seen.
Given these ﬁndings, and the data from Lin28a deleted mice, we
hypothesized that disruption of LIN28A might lead to a failure of
germ cell expansion and, ultimately, germ cell depletion and POI.
However, we did not ﬁnd any non-synonymous variants in LIN28A
in a cohort of women with POI of unknown etiology. Further stud-
ies would be needed to establish whether disruption of LIN28A can
be associated with more signiﬁcant clinical phenotypes in rare
cases, such as growth restriction and impaired insulin sensitivity,
as well as ovarian insufﬁciency, or whether relative expression of
LIN28A through copy number changes or through variable gene
regulation could inﬂuence POI phenotypes. However, changes in
the LIN28A gene are unlikely to be a common cause of more typical
forms of POI.
In conclusion, this study shows that LIN28A is strongly ex-
pressed during early human germ cell development but that alter-
ations in this gene are not a common cause of POI.
Fig. 2. Immunohistochemistry showing expression of POU5F1 (OCT4) (red) and LIN28A (green) in the human ovary at 7 wpc. (A) Low power image showing a population of
LIN28A expressing cells in the peripheral cortical region of the developing gland. Lower level expression of LIN28A was seen in some somatic cells. Scale bar, 100 lm. (B)
LIN28A shows strong staining in this population of POU5F1 (OCT4)-expressing germ cells. Scale bar, 100 lm. (C) High power image showing LIN28A staining mainly in the
cytoplasm of germ cells whereas POU5F1 (OCT4) staining was intense in the nuclei. Scale bar, 10 lm. (D) The omission of primary antibody resulted in very minimal signal.
Scale bar, 100 lm. Nuclei are counterstained with DAPI (blue).
Fig. 3. Immunohistochemistry showing expression of POU5F1 (OCT4) (red) and LIN28A (green) in the human testis at 9 wpc. (A) Low power image showing generalized low
level expression of LIN28A with denser signal in the developing seminiferous cords. Scale bar, 100 lm. (B) High power image showing no clear increased intensity of LIN28A
in POU5F1 (OCT4) expressing cells. Scale bar, 25 lm. (C) Control image showing omission of primary antibody resulted in no signiﬁcant signal. Scale bar, 100 lm. Nuclei are
counterstained with DAPI (blue).
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